Fluconazole and Keytruda drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fluconazole (fluconazole) and Keytruda (pembrolizumab). Common drug interactions include drug ineffective among females and anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Fluconazole and Keytruda. It is created by eHealthMe based on reports of 88 people who take the same drugs from the FDA, and is updated regularly.

What is Fluconazole?

Fluconazole has active ingredients of fluconazole. It is often used in vaginal yeast infection. eHealthMe is studying from 70,481 Fluconazole users. Check the latest studies of Fluconazole.

What is Keytruda?

Keytruda has active ingredients of pembrolizumab. It is often used in renal cell carcinoma. eHealthMe is studying from 57,404 Keytruda users. Check the latest studies of Keytruda.



On Jul, 14, 2026

88 people who take Fluconazole and Keytruda together, and have interactions are studied.

Fluconazole and Keytruda drug interactions.

What are the common drug interactions of Fluconazole and Keytruda, by gender? *:

female:

  1. Drug ineffective
  2. Dry skin
  3. Dysphagia (a condition in which swallowing is difficult or painful)
  4. Dysphonia (speech disorder attributable to a disorder of phonation)
  5. Eye pruritus (eye itching)
  6. Fall
  7. Gait disturbance
  8. General physical health deterioration (weak health status)
  9. Hyperkeratosis (thickening of the outer layer of the skin)
  10. Localised infection (infection at the single location)

male:

  1. Anaemia (lack of blood)
  2. Histiocytosis haematophagic
  3. Ileus (a painful obstruction of the ileum or other part of the intestine)
  4. Malaise (a feeling of general discomfort or uneasiness)
  5. Muscular weakness (muscle weakness)
  6. Myelitis (infection or the inflammation of white matter or gray matter of spinal cord which is a part of central nervous system)
  7. Urinary retention (the inability to completely or partially empty the bladder)
  8. Hepatitis c
  9. Arthralgia (joint pain)
  10. Dysuria (painful or difficult urination)

What are the common drug interactions of Fluconazole and Keytruda, by age (0-1 to 60+)? *:

0-1:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Premature baby

2-9:

n/a

10-19:

n/a

20-29:

  1. Swollen tongue (swelling of tongue)
  2. Vomiting
  3. Wheezing (a high-pitched whistling sound made while you breath)
  4. Dizziness
  5. Dyspnoea (difficult or laboured respiration)
  6. Flushing (the warm, red condition of human skin)
  7. Heart rate increased
  8. Maternal exposure during pregnancy (use of substance during pregnancy)
  9. Nausea (feeling of having an urge to vomit)
  10. Premature delivery

30-39:

  1. Blood creatinine increased
  2. Prerenal failure
  3. Renal failure (kidney dysfunction)

40-49:

n/a

50-59:

  1. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  2. Lichenoid keratosis (a skin disorder described by rapid growing, reddish to brown, benign (noncancerous) lesion on the skin)
  3. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  4. Hypertriglyceridaemia (excess of triglycerides in the blood)
  5. Hepatitis c
  6. Alanine aminotransferase increased
  7. Ataxia (loss of full control of bodily movements)
  8. Back pain
  9. Catheter site haemorrhage (bleeding at catheter site)
  10. Cns ventriculitis (inflammation of the ventricles in the brain)

60+:

  1. Pneumonia
  2. Pulmonary embolism (blockage of the main artery of the lung)
  3. Mixed liver injury
  4. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  5. Dysphonia (speech disorder attributable to a disorder of phonation)
  6. Oral pain
  7. Rash erythematous (redness of the skin)
  8. Weight decreased
  9. Arthralgia (joint pain)
  10. Gait disturbance

What are the existing conditions these people have? *

  1. Pneumonia: 25 people, 28.41%
  2. Non-Small Cell Lung Cancer Stage 0: 24 people, 27.27%
  3. Insomnia (sleeplessness): 12 people, 13.64%
  4. Lung Cancer - Non-Small Cell (lung cancer): 11 people, 12.50%
  5. High Blood Pressure: 11 people, 12.50%
  6. Prostatitis (inflammation of the prostate gland): 9 people, 10.23%
  7. Pain: 9 people, 10.23%
  8. Lung Adenocarcinoma (a form of non-small cell lung cancer): 9 people, 10.23%
  9. Lung Neoplasm Malignant (cancer tumour of lung): 5 people, 5.68%
  10. Diabetes: 5 people, 5.68%

* Approximation only. Some reports may have incomplete information.

Do you take Fluconazole and Keytruda?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fluconazole and Keytruda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fluconazole:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Keytruda:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fluconazole and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Keytruda and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on fluconazole and pembrolizumab (the active ingredients of Fluconazole and Keytruda, respectively), and Fluconazole and Keytruda (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: